MUC1和MUC16在胆囊癌中的研究进展

doi:10.11904/j.issn.1002-3070.2016.06.019

实用肿瘤学杂志 ›› 2016, Vol. 30 ›› Issue (6): 568-571.doi: 10.11904/j.issn.1002-3070.2016.06.019

MUC1和MUC16在胆囊癌中的研究进展

朱彤，陶宣辰，综述，孙世波，审校

哈尔滨医科大学附属第二医院普外科(哈尔滨 150001)

收稿日期:2016-06-03 出版日期:2016-12-31 发布日期:2016-12-27
通讯作者: 孙世波,E-mail:shibosun8@hotmail.com
作者简介:朱彤，男，(1991-)，硕士研究生，从事肿瘤外科学的研究

Research progress of MUC1 and MUC16 in gallblader carcinoma

ZHU Tong,TAO Xuanchen,SUN Shibo

Department of General Surgery,The Second Affiliated Hospital of Harbin Medical University,Harbin 150001,China

Received:2016-06-03 Online:2016-12-31 Published:2016-12-27

摘要/Abstract

摘要： 黏蛋白(MUC)是由上皮细胞分泌的一类高分子化、高度糖基化的糖蛋白，广泛存在于呼吸系统、消化系统、泌尿生殖系统的黏膜上皮及其分泌的黏液中。目前研究表明，黏蛋白家族与肿瘤关系密切。其中MUC1(CA153)及MUC16(CA125)已被证实在胆管癌中异常表达，但未明确二者与胆囊癌的发生发展、侵袭转移及判断预后有密切的关系。本文通过对近年来国内外文献进行回顾性分析，对MUC1和MUC16在胆囊癌中的研究进展进行综述。

关键词: 黏蛋白1, 黏蛋白16, 胆囊癌, 肿瘤标记物

Abstract: Mucins(MUC)are secreted by the epithelial cells of polymer,the height of glycosylation glycoprotein,widely existing in the respiratory system,digestive system,urogenital system in the mucosa epithelium and mucus secretion.The resent studies show that sticks are closely associated with tumor protein family.Among them,the sticky protein 1(CA153)and 16 mucins(CA125)has been confirmed that the abnormal expression in the bile duct carcinoma.However,there is unclear relationship between the development,invasion,metastasis and prognosis of gallbladder.Based on the retrospective literature at home and abroad in recent years,the research progress on the sticky protein 1 and mucins 16 in the gallbladder is summarized in the present review.

Key words: MUC1, MUC16, Gallbladder carcinoma, Tumor marker

中图分类号:

R735.8

朱彤，陶宣辰，综述，孙世波，审校. MUC1和MUC16在胆囊癌中的研究进展[J]. 实用肿瘤学杂志, 2016, 30(6): 568-571.

ZHU Tong,TAO Xuanchen,SUN Shibo. Research progress of MUC1 and MUC16 in gallblader carcinoma[J]. PRACTICAL ONCOLOGY JOURNAL, 2016, 30(6): 568-571.

参考文献

1 Beck Z,Brown BK,Matyas GR,et al.Infection of human peripheral blood mononuclear cells by erythrocyte-bound HIV-1:effects of antibodies and complement[J].Virology,2011,412(2):441-447.
2 Wernberg JA,Lucarelli DD.Gallbladder cancer[J].Surg Clin North Am,2014,94(2):343-360.
3 Razumilava N,Gores GJ.Cholangiocarcinoma[J].Lancet,2014,383(9935):2168-2179.
4 McGuckin MA,Linden SK,Sutton P,et al.Mucin dynamics and enteric pathogens[J].Nat Rev Microbiol,2011,9(4):265-278.
5 hang LF,Hou CS,Liu JY,et al.Strategies for diagnosis of xanthogranulomatous cholecystitis masquerading as gallbladder cancer[J].Chin Med J,2012,125(1):109-113.
6 Xiong L,Yang Z,Yang L,et al.Expressive levels of MUC1 and MUC5AC and their clinicopathologic significances in the benign and malignant lesions of gallbladder[J].J Surg Oncol,2012,105(1):97 -103.
7 王健东,全志伟.胆囊癌手术方式的选择与技术要点[J].中国实用外科杂志,2015,35(9):1022-1024.
8 Von M S,Snijdewint F G,Verstraeten A A,et al.Human MUC1 mucin:a multifaceted glycoprotein[J].Int J Biol Markers,2000,15(4):343-356.
9 Yamasaki H,Ikeda S,Okajima M,et al.Expression and localization of MUC1,MUC2,MUC5AC and small intestinal mucin antigen in pancreatic tumors[J].Int J Oncol,2004,24(1):107-13.
10 Kaur S,Sharma N,Krishn SR,et al.MUC4-mediated regulation of acute plase protein lipocalin 2 through HER2/AKT/NF-kappaB signaling in pancreatic cancer[J].Clin Cancer Res,2014,20(3):688-700.
11 段海章,李凡,孙岩.黏蛋白在胆管癌中的研究进展[J].现代肿瘤医学,2015(22):3357-3360.
12 Yang H,Cho NH,Seong SY.The Tat-conjugated N-terminal region of mucin antigen(MUC1)induces protective immunity against MUC1-expressing tumours[J].Clin Exp Immunol,2009,158(2):174-185.
13 Croce MV,Isla-Larrain MT,Demichelis SO,et al.Tissue and serum MUC1 mucin detection in breast cancer patients[J].Breast Cancer Res Treat,2003,81(3):195-207.
14 Hollingsworth MA,Swanson BJ.Mucins in cancer:Protection and control of the cell surface[J].Nature Reviews Cancer,2004,4(1):45-60.
15 Kocer B,Soran A,Kiyak G,et al.Prognostic significance of mucin expression in gastric carcinoma[J].Dig Dis Sci,2004,49(6):954-964.
16 Xu H,Inagaki Y,Tang W,et al.Elevation of serum KL-6 mucin levels in patients with cholangiocarcinoma[J].Hepatogastroenterology,2008,55(88):2000-2004.
17 张凤博,孙岩.黏蛋白在原发性胆囊癌中的研究进展[J].肝胆胰外科杂志,2015,27(2):167-170.
18 Hollingsworth M A,Swanson B J.Mucins in cancer:protection and control of the cell surface[J].Nature Reviews Cancer,2004,4(4):45-60.
19 Castillo C,Buob D,Mortuaire G.Signet-ring cell adeno-carcinoma of sinonasal tract:an immunohistochemical study of the mucins profile[J].Arch Pathol Lab Med,2007,131(6):961-964.
20 Cozzi PJ,Wang J,Delprado W,et al.MUC1,MUC2,MUC3,MUC4,MUC5 and MUC6 expression in the progression of prostate cancer[J].J Clin Exp Metastasis,2005,22(7):565-573.
21 Ghosh M,Kamma H,Kawamoto T,et al.MUC 1 core protein as a marker of gallbladder malignancy[J].Eur J Surg One,2005,3 1(8):891-896.
22 张华洋,孔棣,马波.胆囊癌生物学标志物研究进展[J].中国普通外科杂志,2014,23(8):1112-1116.
23 冷恩仁,郑伟,陈东风.粘蛋白在结石性胆囊炎及癌前病变转化中的作用[J].现代消化及介入诊疗,2002,7(2):50-54.
24 Zhang W,Li GY,Shi CJ,et al.Liquid biquid based cytology for detection of peritoneal effusion CA125 in the diagnosis of ovarian cancer[J].Chin Med Clin,2014,14(3):398-399.
25 Chen CY,Shiesh SC,Tsao HC,et al.The assessment of biliary CA125,CA199 and CEA in diagnosing cholangiocarcinoma-the influence of sampling time and hepatolithiasis[J].Hepatogastroenterology,2002,49(45):616-620.
26 Higashi M,Yamada N,Yokoyama S,et al.Pathobiological implications of MUC16/CA125 expression in intrahepatic cholangiocarcinoma-mass forming type[J].Pathobiology,2012,79(2):101-106.
27 Ohtsuka M,Ito H,Kimura F,et al.Results of surgical treatment for intrahepatic cholangiocarcinoma and clinicopathological factors influencing survival[J].Br J Surg,2002,89(12):1525-1531.
28 Liu X,Wang HL.Detection of CEA,CA199,CA50,CA125 in the application of the gallbladder early diagnosis and prognosis judgement[J].Chinese Journal of Misdiagnostics,2009,9(3):577-578.
29 罗万红,邹声泉.黏蛋白1在胆囊癌中的表达和意义[J].中华消化外科杂志,2006,5(1):67-69.
30 王云峰.肿瘤标志物联合检测在胆囊癌诊断和预后的价值[D].济南:山东大学,2014.

[1]	陈兆红, 何迎盈, 张友才, 鲁丁瑜. 过表达SOX7对胆囊癌GBC-SD细胞增殖生物学特性的影响及其机制研究[J]. 实用肿瘤学杂志, 2018, 32(4): 293-297.
[2]	钱六七, 刘芊, 刘毅, 张少华, 王涛, 吴世凯, 宋三泰, 刘兵, 江泽飞. 循环肿瘤细胞在转移性乳腺癌中的表达及其与多种血清肿瘤标志物的关系[J]. 实用肿瘤学杂志, 2012, 26(3): 220-224.
[3]	季柏林;王雪春;赵建刚;康云平;杨关根;黄常新. 部分肿瘤标志物与晚期结直肠癌疗效关系的临床观察[J]. 实用肿瘤学杂志, 2008, 22(03): 265-266,.
[4]	董静波. 原发性胆囊癌25例临床分析[J]. 实用肿瘤学杂志, 2005, 19(04): 303-304.
[5]	任秋华;侯慧;徐艳丽;景士兵. 胃肠道间质瘤多种肿瘤标记物的表达及临床意义[J]. 实用肿瘤学杂志, 2004, 18(06): 466-467.
[6]	施红旗;刘庆伟. p53蛋白和PCNA在胆囊癌中的表达与预后的关系[J]. 实用肿瘤学杂志, 2003, 17(03): 182-184.
[7]	吴洪芬;李洁;赵瑞珅;南英姬;张强. 胆囊癌的CT诊断[J]. 实用肿瘤学杂志, 2001, 15(04): 309-310.
[8]	黄成;郑莉;辛颖波;李群;郑吉南;时晓敏. 胆囊癌的CT诊断 (附10例分析)[J]. 实用肿瘤学杂志, 2000, 14(02): 148-148.

MUC1和MUC16在胆囊癌中的研究进展

Research progress of MUC1 and MUC16 in gallblader carcinoma

PDF

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 8

编辑推荐

Metrics

本文评价